• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度学习可区分异柠檬酸脱氢酶(IDH)突变型与IDH野生型胶质母细胞瘤。

Deep Learning Can Differentiate IDH-Mutant from IDH-Wild GBM.

作者信息

Pasquini Luca, Napolitano Antonio, Tagliente Emanuela, Dellepiane Francesco, Lucignani Martina, Vidiri Antonello, Ranazzi Giulio, Stoppacciaro Antonella, Moltoni Giulia, Nicolai Matteo, Romano Andrea, Di Napoli Alberto, Bozzao Alessandro

机构信息

Neuroradiology Unit, NESMOS Department, Sant'Andrea Hospital, La Sapienza University, Via di Grottarossa 1035, 00189 Rome, Italy.

Neuroradiology Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.

出版信息

J Pers Med. 2021 Apr 9;11(4):290. doi: 10.3390/jpm11040290.

DOI:10.3390/jpm11040290
PMID:33918828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8069494/
Abstract

Isocitrate dehydrogenase (IDH) mutant and wildtype glioblastoma multiforme (GBM) often show overlapping features on magnetic resonance imaging (MRI), representing a diagnostic challenge. Deep learning showed promising results for IDH identification in mixed low/high grade glioma populations; however, a GBM-specific model is still lacking in the literature. Our aim was to develop a GBM-tailored deep-learning model for IDH prediction by applying convoluted neural networks (CNN) on multiparametric MRI. We selected 100 adult patients with pathologically demonstrated WHO grade IV gliomas and IDH testing. MRI sequences included: MPRAGE, T1, T2, FLAIR, rCBV and ADC. The model consisted of a 4-block 2D CNN, applied to each MRI sequence. Probability of IDH mutation was obtained from the last dense layer of a softmax activation function. Model performance was evaluated in the test cohort considering categorical cross-entropy loss (CCEL) and accuracy. Calculated performance was: rCBV (accuracy 83%, CCEL 0.64), T1 (accuracy 77%, CCEL 1.4), FLAIR (accuracy 77%, CCEL 1.98), T2 (accuracy 67%, CCEL 2.41), MPRAGE (accuracy 66%, CCEL 2.55). Lower performance was achieved on ADC maps. We present a GBM-specific deep-learning model for IDH mutation prediction, with a maximal accuracy of 83% on rCBV maps. Highest predictivity achieved on perfusion images possibly reflects the known link between IDH and neoangiogenesis through the hypoxia inducible factor.

摘要

异柠檬酸脱氢酶(IDH)突变型和野生型多形性胶质母细胞瘤(GBM)在磁共振成像(MRI)上常表现出重叠特征,这构成了诊断挑战。深度学习在混合低/高级别胶质瘤群体的IDH识别方面显示出有前景的结果;然而,文献中仍缺乏GBM特异性模型。我们的目的是通过在多参数MRI上应用卷积神经网络(CNN)来开发一种针对GBM的深度学习模型用于IDH预测。我们选择了100例经病理证实为WHO四级胶质瘤且进行了IDH检测的成年患者。MRI序列包括:MPRAGE、T1、T2、FLAIR、rCBV和ADC。该模型由一个4模块的二维CNN组成,应用于每个MRI序列。IDH突变的概率从softmax激活函数的最后一个全连接层获得。在测试队列中,考虑分类交叉熵损失(CCEL)和准确率来评估模型性能。计算得到的性能如下:rCBV(准确率83%,CCEL 0.64)、T1(准确率77%,CCEL 1.4)、FLAIR(准确率77%,CCEL 1.98)、T2(准确率67%,CCEL 2.41)、MPRAGE(准确率66%,CCEL 2.55)。ADC图的性能较低。我们提出了一种用于IDH突变预测的GBM特异性深度学习模型,在rCBV图上的最大准确率为83%。灌注图像上实现的最高预测性可能反映了IDH与通过缺氧诱导因子的新生血管生成之间的已知联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/804d69d796e5/jpm-11-00290-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/7798fc7d002b/jpm-11-00290-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/e24f738277a8/jpm-11-00290-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/c7e94e25b4cd/jpm-11-00290-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/c5ee669472c2/jpm-11-00290-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/c578f9cc0fa8/jpm-11-00290-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/804d69d796e5/jpm-11-00290-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/7798fc7d002b/jpm-11-00290-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/e24f738277a8/jpm-11-00290-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/c7e94e25b4cd/jpm-11-00290-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/c5ee669472c2/jpm-11-00290-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/c578f9cc0fa8/jpm-11-00290-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/777c/8069494/804d69d796e5/jpm-11-00290-g006.jpg

相似文献

1
Deep Learning Can Differentiate IDH-Mutant from IDH-Wild GBM.深度学习可区分异柠檬酸脱氢酶(IDH)突变型与IDH野生型胶质母细胞瘤。
J Pers Med. 2021 Apr 9;11(4):290. doi: 10.3390/jpm11040290.
2
Prediction of IDH Mutation Status in High-grade Gliomas Using DWI and High T1-weight DSC-MRI.使用 DWI 和高 T1 加权 DSC-MRI 预测高级别胶质瘤的 IDH 突变状态。
Acad Radiol. 2022 Mar;29 Suppl 3:S52-S62. doi: 10.1016/j.acra.2021.02.002. Epub 2021 Mar 6.
3
T2/FLAIR-mismatch sign for noninvasive detection of IDH-mutant 1p/19q non-codeleted gliomas: validity and pathophysiology.用于无创检测异柠檬酸脱氢酶(IDH)突变的1p/19q非共缺失型胶质瘤的T2/液体衰减反转恢复序列(FLAIR)不匹配征象:有效性及病理生理学
Neurooncol Adv. 2020 Jan 10;2(1):vdaa004. doi: 10.1093/noajnl/vdaa004. eCollection 2020 Jan-Dec.
4
Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.世界卫生组织II - III级弥漫性胶质瘤组织学和基因亚型中的灌注及扩散磁共振成像特征
J Neurooncol. 2017 Aug;134(1):177-188. doi: 10.1007/s11060-017-2506-9. Epub 2017 May 25.
5
T2-FLAIR mismatch sign and machine learning-based multiparametric MRI radiomics in predicting IDH mutant 1p/19q non-co-deleted diffuse lower-grade gliomas.T2-FLAIR 错配征象及基于机器学习的多参数 MRI 放射组学在预测 IDH 突变 1p/19q 非共缺失弥漫性低级别胶质瘤中的应用。
Clin Radiol. 2024 May;79(5):e750-e758. doi: 10.1016/j.crad.2024.01.021. Epub 2024 Feb 2.
6
Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign.高级影像学参数可提高弥漫性低级别胶质瘤 IDH 突变型无 1p19q 联合缺失亚型的预测准确性:T2/FLAIR 不匹配征象的附加价值。
Eur Radiol. 2020 Feb;30(2):844-854. doi: 10.1007/s00330-019-06395-2. Epub 2019 Aug 24.
7
Identification of IDH and TERTp mutations using dynamic susceptibility contrast MRI with deep learning in 162 gliomas.应用深度学习的动态磁敏感对比 MRI 对 162 例胶质瘤患者的 IDH 和 TERTp 突变进行鉴定。
Eur J Radiol. 2024 Jan;170:111257. doi: 10.1016/j.ejrad.2023.111257. Epub 2023 Dec 13.
8
Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.弥散加权和灌注加权 MRI 放射组学模型可预测弥漫性低级别胶质瘤中的异柠檬酸脱氢酶 (IDH) 突变和肿瘤侵袭性。
Eur Radiol. 2020 Apr;30(4):2142-2151. doi: 10.1007/s00330-019-06548-3. Epub 2019 Dec 11.
9
Reproducible imaging-based prediction of molecular subtype and risk stratification of gliomas across different experience levels using a structured reporting system.基于可重复成像的预测,使用结构化报告系统在不同经验水平下对脑胶质瘤的分子亚型和风险分层进行预测。
Eur Radiol. 2021 Oct;31(10):7374-7385. doi: 10.1007/s00330-021-08015-4. Epub 2021 Aug 10.
10
Differentiating between glioblastomas with and without isocitrate dehydrogenase gene mutation by findings on conventional magnetic resonance images.通过常规磁共振成像表现鉴别伴有和不伴有异柠檬酸脱氢酶基因突变的胶质母细胞瘤。
J Clin Neurosci. 2020 Jun;76:140-144. doi: 10.1016/j.jocn.2020.04.016. Epub 2020 Apr 11.

引用本文的文献

1
Advanced MRI, Radiomics and Radiogenomics in Unravelling Incidental Glioma Grading and Genetic Status: Where Are We?高级磁共振成像、影像组学和放射基因组学在解读偶然发现的胶质瘤分级和基因状态中的应用:我们目前的进展如何?
Medicina (Kaunas). 2025 Aug 12;61(8):1453. doi: 10.3390/medicina61081453.
2
Bridging the clinical gap: Confidence informed IDH prediction in brain gliomas using MRI and deep learning.弥合临床差距:利用磁共振成像(MRI)和深度学习实现脑胶质瘤中异柠檬酸脱氢酶(IDH)预测的信心告知
Neurooncol Adv. 2025 Jul 25;7(1):vdaf142. doi: 10.1093/noajnl/vdaf142. eCollection 2025 Jan-Dec.
3
Diagnostic performance of deep learning for predicting glioma isocitrate dehydrogenase and 1p/19q co-deletion in MRI: a systematic review and meta-analysis.

本文引用的文献

1
Text Data Augmentation for Deep Learning.用于深度学习的文本数据增强
J Big Data. 2021;8(1):101. doi: 10.1186/s40537-021-00492-0. Epub 2021 Jul 19.
2
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading.cIMPACT-NOW更新6:关于未来中枢神经系统肿瘤分类和分级的cIMPACT-乌得勒支会议的新实体和诊断原则建议。
Brain Pathol. 2020 Jul;30(4):844-856. doi: 10.1111/bpa.12832. Epub 2020 Apr 19.
3
IDH mutation in glioma: molecular mechanisms and potential therapeutic targets.
深度学习在磁共振成像中预测胶质瘤异柠檬酸脱氢酶和1p/19q共缺失的诊断性能:一项系统评价和荟萃分析
Eur Radiol. 2025 Aug 16. doi: 10.1007/s00330-025-11898-2.
4
Predicting the molecular subtypes of 2021 WHO grade 4 glioma by a multiparametric MRI-based machine learning model.基于多参数磁共振成像的机器学习模型预测2021年世界卫生组织4级胶质瘤的分子亚型
BMC Cancer. 2025 Jul 14;25(1):1171. doi: 10.1186/s12885-025-14529-7.
5
A Review of Artificial Intelligence-Based Systems for Non-Invasive Glioblastoma Diagnosis.基于人工智能的非侵入性胶质母细胞瘤诊断系统综述
Life (Basel). 2025 Apr 14;15(4):643. doi: 10.3390/life15040643.
6
Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi Study.加拿大胶质母细胞瘤诊断与管理专家共识建议:德尔菲研究结果
Curr Oncol. 2025 Apr 1;32(4):207. doi: 10.3390/curroncol32040207.
7
Context aware machine learning techniques for brain tumor classification and detection - A review.用于脑肿瘤分类与检测的上下文感知机器学习技术——综述
Heliyon. 2025 Jan 13;11(2):e41835. doi: 10.1016/j.heliyon.2025.e41835. eCollection 2025 Jan 30.
8
Non-invasive classification of IDH mutation status of gliomas from multi-modal MRI using a 3D convolutional neural network.使用三维卷积神经网络从多模态磁共振成像对胶质瘤的异柠檬酸脱氢酶(IDH)突变状态进行无创分类。
Proc SPIE Int Soc Opt Eng. 2023 Feb;12465. doi: 10.1117/12.2651391. Epub 2023 Apr 7.
9
Advanced magnetic resonance imaging for glioblastoma: Oncology-radiology integration.胶质母细胞瘤的高级磁共振成像:肿瘤学与放射学的整合
Surg Neurol Int. 2024 Aug 30;15:309. doi: 10.25259/SNI_498_2024. eCollection 2024.
10
Sexually dimorphic computational histopathological signatures prognostic of overall survival in high-grade gliomas via deep learning.通过深度学习构建的性二态计算组织病理学特征对高级别胶质瘤患者总生存期的预测。
Sci Adv. 2024 Aug 23;10(34):eadi0302. doi: 10.1126/sciadv.adi0302.
胶质母细胞瘤中的 IDH 突变:分子机制与潜在治疗靶点。
Br J Cancer. 2020 May;122(11):1580-1589. doi: 10.1038/s41416-020-0814-x. Epub 2020 Apr 15.
4
Radiomics in gliomas: clinical implications of computational modeling and fractal-based analysis.脑胶质瘤的放射组学:基于计算模型和分形分析的临床意义。
Neuroradiology. 2020 Jul;62(7):771-790. doi: 10.1007/s00234-020-02403-1. Epub 2020 Apr 6.
5
Vascular habitat analysis based on dynamic susceptibility contrast perfusion MRI predicts IDH mutation status and prognosis in high-grade gliomas.基于动态磁敏感对比灌注 MRI 的血管生境分析预测高级别胶质瘤 IDH 突变状态和预后。
Eur Radiol. 2020 Jun;30(6):3254-3265. doi: 10.1007/s00330-020-06702-2. Epub 2020 Feb 20.
6
The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?肿瘤异质性的多个方面:代谢是否滞后?
Cancers (Basel). 2019 Oct 16;11(10):1574. doi: 10.3390/cancers11101574.
7
Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review.胶质母细胞瘤分子特征的影像学特征:放射基因组学综述。
J Magn Reson Imaging. 2020 Jul;52(1):54-69. doi: 10.1002/jmri.26907. Epub 2019 Aug 27.
8
Genetic and molecular epidemiology of adult diffuse glioma.成人弥漫性神经胶质瘤的遗传和分子流行病学。
Nat Rev Neurol. 2019 Jul;15(7):405-417. doi: 10.1038/s41582-019-0220-2. Epub 2019 Jun 21.
9
Optimizing Neuro-Oncology Imaging: A Review of Deep Learning Approaches for Glioma Imaging.优化神经肿瘤影像学:胶质瘤成像深度学习方法综述
Cancers (Basel). 2019 Jun 14;11(6):829. doi: 10.3390/cancers11060829.
10
Multi-Channel 3D Deep Feature Learning for Survival Time Prediction of Brain Tumor Patients Using Multi-Modal Neuroimages.基于多模态神经影像的多通道 3D 深度特征学习在脑肿瘤患者生存时间预测中的应用。
Sci Rep. 2019 Jan 31;9(1):1103. doi: 10.1038/s41598-018-37387-9.